Molecular determinant of clinical response to ONC201, an inhibitor of dopamine receptor 2 (DRD2) signaling, in glioblastoma patient.

Jie Li; Jun Ma; Yuyu He; Varun Vijay  Prabhu; Joshua Allen; Clark C Chen

Molecular determinant of clinical response to ONC201, an inhibitor of dopamine receptor 2 (DRD2) signaling, in glioblastoma patient.

Jie Li, Jun Ma, Yuyu He, Varun Vijay Prabhu, Joshua Allen, Clark C Chen

Neurosurgery

Research output: Contribution to conference › Poster

Abstract

Jie Li, Jun Ma, Yuyu He, Varun Vijay Prabhu, Joshua Allen, Clark Chen. Molecular determinant of clinical response to ONC201, an inhibitor of dopamine receptor 2 (DRD2) signaling, in glioblastoma patient. — 23rd Annual Meeting of the Society for Neuro-Oncology. (Physical poster. Neuro-Oncology 20(suppl_6):vi90-vi90. November 15-18, 2018.)

Original language	English (US)
State	Published - 2018

Find It

Find It at U of M Libraries

Cite this

@conference{fba39325e5c04b14a2c004b901fe3bae,

title = "Molecular determinant of clinical response to ONC201, an inhibitor of dopamine receptor 2 (DRD2) signaling, in glioblastoma patient.",

abstract = "Jie Li, Jun Ma, Yuyu He, Varun Vijay Prabhu, Joshua Allen, Clark Chen. Molecular determinant of clinical response to ONC201, an inhibitor of dopamine receptor 2 (DRD2) signaling, in glioblastoma patient. — 23rd Annual Meeting of the Society for Neuro-Oncology. (Physical poster. Neuro-Oncology 20(suppl_6):vi90-vi90. November 15-18, 2018.)",

author = "Jie Li and Jun Ma and Yuyu He and Prabhu, {Varun Vijay} and Joshua Allen and Chen, {Clark C}",

year = "2018",

language = "English (US)",

}

TY - CONF

T1 - Molecular determinant of clinical response to ONC201, an inhibitor of dopamine receptor 2 (DRD2) signaling, in glioblastoma patient.

AU - Li, Jie

AU - Ma, Jun

AU - He, Yuyu

AU - Prabhu, Varun Vijay

AU - Allen, Joshua

AU - Chen, Clark C

PY - 2018

Y1 - 2018

N2 - Jie Li, Jun Ma, Yuyu He, Varun Vijay Prabhu, Joshua Allen, Clark Chen. Molecular determinant of clinical response to ONC201, an inhibitor of dopamine receptor 2 (DRD2) signaling, in glioblastoma patient. — 23rd Annual Meeting of the Society for Neuro-Oncology. (Physical poster. Neuro-Oncology 20(suppl_6):vi90-vi90. November 15-18, 2018.)

AB - Jie Li, Jun Ma, Yuyu He, Varun Vijay Prabhu, Joshua Allen, Clark Chen. Molecular determinant of clinical response to ONC201, an inhibitor of dopamine receptor 2 (DRD2) signaling, in glioblastoma patient. — 23rd Annual Meeting of the Society for Neuro-Oncology. (Physical poster. Neuro-Oncology 20(suppl_6):vi90-vi90. November 15-18, 2018.)

M3 - Poster

ER -

Molecular determinant of clinical response to ONC201, an inhibitor of dopamine receptor 2 (DRD2) signaling, in glioblastoma patient.

Abstract

Find It

Fingerprint

Cite this